SKAP2 promotes podosome formation to facilitate tumor-associated macrophage infiltration and metastatic progression

Cancer Research

Volumn 76, Issue 2, 2016, Pages 358-369

  Tanaka, Masamitsu ^a   Shimamura, Shintaro ^a,b   Kuriyama, Sei ^a   Maeda, Daichi ^a   Goto, Akiteru ^a   Aiba, Namiko ^a  

^a AKITA UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PHOSPHOPROTEIN; PROTEIN SKAP2; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN; SIGNAL PEPTIDE; SRC KINASE ASSOCIATED PHOSPHOPROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER CELL LINE; CANCER GROWTH; CARCINOGENESIS; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER CELL LINE; METASTASIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PODOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; ANIMAL; BREAST TUMOR; C57BL MOUSE; DISEASE COURSE; EXPERIMENTAL MELANOMA; FEMALE; GENETICS; KNOCKOUT MOUSE; LEWIS CARCINOMA; MACROPHAGE; METABOLISM; PATHOLOGY; RAW 264.7 CELL LINE; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MACROPHAGES, PERITONEAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM METASTASIS; PODOSOMES; RAW 264.7 CELLS;

EID: 84958975827     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1879     Document Type: Article

References (39)

1. Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010;22:231-7.
2. Schmieder A, Michel J, Schonhaar K, Goerdt S, Schledzewski K. Differentiation and gene expression profile of tumor-associated macrophages. Semin Cancer Biol 2012;22:289-97.
3. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39-51.
4. Komohara Y, Jinushi M, Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 2015;105:1-8.
5. Cougoule C, Van Goethem E, Le Cabec V, Lafouresse F, Dupre L,Mehraj V, et al. Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in environments. Eur J Cell Biol 2012;91:938-49.
6. Linder S, Wiesner C, Himmel M, Degrading devices: invadosomes in proteolytic cell invasion. Annu Rev Cell Dev Biol 2011;27:185-211.
7. Gawden-Bone C, Zhou Z, King E, Prescott A, Watts C, Lucocq J. Dendritic cell podosomes are protrusive and invade the extracellular matrix using metalloproteinase MMP-14. J Cell Sci 2010;123:1427-37.
8. Moridonneau-Parini I. Control of macrophage 3D migration: a therapeutic challenge to limit tissue infiltration. Immunol Rev 2014;262: 216-31.
9. Wiesner C, Le-Cabec V, El Azzouzi K, Maridonneau-Parini I, Linder S. Podosomes in space: macrophage migration and matrix degradation in 2D and 3D settings. Cell Adh Migr 2014;8:179-91.
10. Kouroku Y, Soyama A, Fujita E, Urase K, Tsukahara T, Momoi T. RA70 is a src kinase-associated protein expressed ubiquitously. Biochem Biophys Res Commun 1998;252:738-42.
11. Marie-Cardine A, Verhagen AM, Eckerskorn C, Schraven B. SKAP-HOM, a novel adaptor protein homologous to the FYN-associated protein SKAP55. FEBS Lett 1998;435:55-60.
12. Shimamura S, Sasaki K, TanakaM. The Src substrate SKAP2 regulates actin assembly by interacting with WAVE2 and cortactin proteins. J Biol Chem 2013;288:1171-83.
13. Curtis DJ, Jane SM, Hilton DJ, Dougherty L, Bodine DM, Begley CG. Adaptor protein SKAP55R is associated with myeloid differentiation and growth arrest. Exp Hematol 2000;28:1250-9.
14. Macias MJ, Wiesner S, Sudol M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett 2002;513:30-7.
15. Swanson KD, Tang Y, Ceccarelli DF, Poy F, Sliwa JP, Neel BG, et al. The Skap-homdimerization andPHdomains comprise a 30-phosphoinositidegated molecular switch. Mol Cell 2008;32:564-75.
16. Black DS, Marie-Cardine A, Schraven B, Bliska JB. The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cell Microbiol 2000;2:401-14.
17. Bourette RP, Therier J, Mouchiroud G. Macrophage colony-stimulating factor receptor induces tyrosine phosphorylation of SKAP55R adaptor and its association with actin. Cell Signal 2005;17:941-9..
18. Reinhold A, Reimann S, Reinhold D, Schraven B, Togni M. Expression of SKAP-HOM in DCs is required for an optimal immune response in vivo. J Leukoc Biol 2009;86:61-71.
19. Togni M, Swanson KD, Reimann S, Kliche S, Pearce AC, Simeoni L, et al. Regulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOM. Mol Cell Biol 2005;25:8052-63.
20. Griffiths EK, Krawczyk C, Kong YY, Raab M, Hyduk SJ, Bouchard D, et al. Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science 2001;293:2260-3.
21. Jo EK, Wang H, Rudd CE. An essential role for SKAP-55 in LFA-1 clustering on T cells that cannot be substituted by SKAP-55R. J Exp Med 2005;201: 1733-9.
22. Alenghat FJ, Baca QJ, Rubin NT, Pao LI, Matozaki T, Lowell CA, et al. Macrophages require Skap2 and Sirpa for integrin-stimulated cytoskeletal rearrangement. J Cell Sci 2012;125:5535-45.
23. Takenawa T, Suetsugu S. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 2007;8:37-48.
24. Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci 2005;96:323-32.
25. Satoyoshi R, Kuriyama S, Namiko A, Yashiro M, Tanaka M. Asporin activates coordinated invasion of scirrhous gastric cancer and cancer associated fibroblasts. Oncogene 2015;29:650-60.
26. Linder S, Kopp P. Podosomes at a glance. J Cell Sci 2005;118:2079-82.
27. Buccione R, Orth JD, McNiven MA. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 2004;5:647-57.
28. Linder S, Aepfelbacher M. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 2003;13:376-85.
29. Kocher HM, Sandle J,Mirza TA, Li NF, Hart IR. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut 2009;58: 271-84.
30. Pei BX, Sun BS, Zhang ZF, Wang AL, Ren P. Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer. J Thorac Cardiovasc Surg 2014;148:1208-16.
31. Dijkgraaf EM, Husinkveld M, Tummers B, Vohelpoel LT, Goedemans R, Nortier JW, et al. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res 2013;73:2480-92.
32. Heusinkveld M, de Vos van Steenwijk PJ, Goedemans R, Ramwadhdoebe TH, Gortyer A, Welters MJ, et al. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. J Immunol 2011;187:1157-65.
33. Wouters M, Dijkgraaf EM, Kuijjer ML, Jordanova ES, Hollema H. Welters M, van der Hoeven J, Daemen T, Kroep JR, Nijman HW, van der Burg SH. Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer. Oncoimmunology 2015;3:e962397.
34. Isobe A, Sawada K, Kinose Y, Ohyagi-Hara C, Nakatsuka E, MakinoH, et al. Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer. PLoS One 2015;10:e0118080.
35. Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression inCD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med 2015;7:754-69.
36. Leung J, Suh W-K. The CD28-B7 family in anti-tumor immunity: emerging concepts in cancer immunotherapy. Immune Netw 2014;14:265-76.
37. Jaiswal S, Jamieson CH, Pang WW,Park CY, Chao MP, Majeti R, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009;138:271-85.
38. Oldenborg PA, Gresham HD, Lindberg FP. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med 2001;193:855-62.
39. Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007;8:1313-23.